|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2010-6-28
|
|
pubmed:abstractText |
Cortical systems involved in the response to medication treatment for Alzheimer's disease (AD) are poorly understood. Preclinical studies have demonstrated the effect of memantine on neuroreceptors and cell physiology, although the impact of treatment on cortical activity in vivo is not known.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1545-7214
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
606-14
|
|
pubmed:meshHeading |
pubmed-meshheading:20220580-Aged,
pubmed-meshheading:20220580-Aged, 80 and over,
pubmed-meshheading:20220580-Alzheimer Disease,
pubmed-meshheading:20220580-Cerebral Cortex,
pubmed-meshheading:20220580-Dopamine Agents,
pubmed-meshheading:20220580-Female,
pubmed-meshheading:20220580-Humans,
pubmed-meshheading:20220580-Male,
pubmed-meshheading:20220580-Memantine,
pubmed-meshheading:20220580-Neuropsychological Tests,
pubmed-meshheading:20220580-Parietal Lobe,
pubmed-meshheading:20220580-Positron-Emission Tomography,
pubmed-meshheading:20220580-Prospective Studies,
pubmed-meshheading:20220580-Temporal Lobe
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Effect of memantine treatment on regional cortical metabolism in Alzheimer's disease.
|
|
pubmed:affiliation |
Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, UCLA, CA, USA. dsultzer@ucla.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|
